# reload+after+2024-01-22 22:26:08.025323
address1§1 North Waukegan Road
city§North Chicago
state§IL
zip§60064-6400
country§United States
phone§847 932 7900
website§https://www.abbvie.com
industry§Drug Manufacturers - General
industryKey§drug-manufacturers-general
industryDisp§Drug Manufacturers - General
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; California Institute for Biomedical Research (Calibr), and BigHat Biosciences, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
fullTimeEmployees§50000
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Richard A. Gonzalez', 'age': 69, 'title': 'Chairman & CEO', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 6948244, 'exercisedValue': 0, 'unexercisedValue': 43528872}, {'maxAge': 1, 'name': 'Mr. Robert A. Michael', 'age': 53, 'title': 'President & COO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 3998042, 'exercisedValue': 0, 'unexercisedValue': 13150419}, {'maxAge': 1, 'name': 'Mr. Scott T. Reents', 'age': 55, 'title': 'Executive VP & CFO', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 2972736, 'exercisedValue': 0, 'unexercisedValue': 5172329}, {'maxAge': 1, 'name': 'Dr. Azita  Saleki-Gerhardt Ph.D.', 'age': 60, 'title': 'Executive VP & COO', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 2576755, 'exercisedValue': 0, 'unexercisedValue': 28534760}, {'maxAge': 1, 'name': 'Mr. Jeffrey Ryan Stewart', 'age': 54, 'title': 'Executive VP & Chief Commercial Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 2983231, 'exercisedValue': 2777988, 'unexercisedValue': 10864175}, {'maxAge': 1, 'name': 'Dr. Thomas J. Hudson M.D.', 'age': 61, 'title': 'Senior VP & Chief Scientific Officer of Global Research', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Elizabeth  Shea', 'title': 'Senior Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sanjay  Narayan', 'title': 'VP, Chief Ethics & Compliance Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Tracie  Haas', 'title': 'Senior Vice President of Corporate Responsibility, Brand & Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Timothy J. Richmond', 'age': 57, 'title': 'Executive VP & Chief Human Resources Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 1121841, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§5
compensationRisk§6
shareHolderRightsRisk§9
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
dividendRate§6.2
dividendYield§0.0382
exDividendDate§1705017600
payoutRatio§1.6027
fiveYearAvgDividendYield§4.49
beta§0.47
priceToSalesTrailing12Months§5.1917853
currency§USD
dateShortInterest§1702598400
forwardEps§11.17
pegRatio§-3.5
lastDividendValue§1.48
lastDividendDate§1697068800
exchange§NYQ
quoteType§EQUITY
shortName§AbbVie Inc.
longName§AbbVie Inc.
firstTradeDateEpochUtc§1357137000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§73238d42-cdcc-3f92-8141-dd675addae10
messageBoardId§finmb_141885706
gmtOffSetMilliseconds§-18000000
targetHighPrice§205.0
targetLowPrice§135.0
targetMeanPrice§168.92
targetMedianPrice§170.0
recommendationMean§2.3
recommendationKey§buy
numberOfAnalystOpinions§24
quickRatio§0.71
earningsGrowth§-0.548
grossMargins§0.69921
ebitdaMargins§0.50769
trailingPegRatio§3.3637
